van de Bruyn, MD
Clinical Cardiac Electrophysiology · Little Rock, ARNPI 1871518522
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,822 of the $7,361 with a category attached, or 65.5%. 23 manufacturers reported payments, led by Biotronik Inc. at 45.0% of the total. Reporting peaked in 2021 at $2,852 and has fallen 78.4% since, to $616 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in AR, where the typical reported total is $22,678.
Across 122 payments — averaging $60.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$3K
- Boston Scientific$2K
- Medtronic$723
- Abbott$371
- Merck$238
- Bayer$216
- plus $988 from 17 others
What the payments were for
- Travel & lodging$2,49934%
- Food & beverage$4,82266%
- Education$401%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 33 | $3,315 |
| Boston Scientific | 10 | $1,509 |
| Medtronic | 8 | $723 |
| Abbott | 6 | $371 |
| Merck | 13 | $238 |
| Bayer | 11 | $216 |
| Siemens Medical Solutions USA, Inc. | 1 | $169 |
| Baxter Healthcare | 2 | $151 |
| Amgen | 7 | $120 |
| Abiomed | 2 | $85 |
| Novo Nordisk | 4 | $62 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $58 |
| Pfizer | 4 | $57 |
| Esperion Therapeutics, Inc. | 3 | $55 |
| Sanofi-aventis U.S. LLC | 3 | $50 |
| Kestra Medical Technology Services, Inc. | 1 | $43 |
| Philips North America LLC | 2 | $37 |
| Johnson & Johnson | 2 | $26 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Exact Sciences | 1 | $16 |
| Irhythm Technologies, Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rivacor$2,291
- Edora$2,291
- Acticor$2,291
- BioMonitor$2,045
- Solia$1,898
- Sentus$394
- Plexa$394
- Azure$251
- Artis zee multi-purpose$169
- Cios Alpha$169
- SelectSecure$160
- AVEIR$150
- Protego$148
- Orsiro Mission$130
- Hillrom - Cardiac Ambulatory Monitor$112
- Edora 8 DR-T$109
- Rivacor 7 DR-T$106
How this compares
$7,361 in reported general payments places this provider in the 20th percentile of 25 clinical cardiac electrophysiology providers in Arkansas.
See all clinical cardiac electrophysiology providers in Arkansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 192 | $146,200 |
| XareltoRivaroxaban | 48 | $35,852 |
| JardianceEmpagliflozin | 47 | $33,371 |
| EliquisApixaban | 30 | $19,460 |
| NexletolBempedoic Acid | 11 | $4,355 |
| Metoprolol Succinate | 69 | $772 |
| Pantoprazole Sodium | 86 | $580 |
| Cilostazol | 30 | $561 |
| Spironolactone | 114 | $547 |
| Potassium Chloride | 39 | $416 |
| Amlodipine Besylate | 60 | $400 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 70 | $360 |
| ClopidogrelClopidogrel Bisulfate | 39 | $277 |
| Pravastatin Sodium | 16 | $236 |
| Carvedilol | 68 | $234 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $26 | $35,85248 claims |
| Boehringer IngelheimJardiance | $14 | $33,37147 claims |
| PfizerEliquis | $57 | $19,46030 claims |
| Esperion Therapeutics, Inc.Nexletol | $55 | $4,35511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 25 clinical cardiac electrophysiology providers in Arkansas.
Other clinical cardiac electrophysiology in Little Rock
- Monica LoLittle Rock$190K
- Sudarone ThihalolipavanLittle Rock$77K
- Prabhat HebbarLittle Rock$75K
- Gerald GreerLittle Rock$41K
- Risheek KaulLittle Rock$38K
- Michael LoguidiceLittle Rock$29K
- Breck SandvallLittle Rock$23K
- Brian NorrisLittle Rock$18K
- Thomas WallaceLittle Rock$14K
- Subodh DevabhaktuniLittle Rock$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.